Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
15,047,623
-
Share change
-
-2,642,211
-
Total reported value
-
$74,486,031
-
Put/Call ratio
-
96%
-
Price per share
-
$4.95
-
Number of holders
-
43
-
Value change
-
-$21,761,430
-
Number of buys
-
14
-
Number of sells
-
42
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q4 2021
As of 31 Dec 2021,
AC Immune SA - SHS (ACIU) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,047,623 shares.
The largest 10 holders included
BVF INC/IL, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, Artal Group S.A., EcoR1 Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, Lombard Odier Asset Management (Switzerland) SA, BlackRock Inc., and DEUTSCHE BANK AG\.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.